Literature DB >> 11038384

Binding of human respiratory syncytial virus to cells: implication of sulfated cell surface proteoglycans.

Isidoro Martínez1, José A Melero1.   

Abstract

Binding of human respiratory syncytial virus (HRSV) to cultured cells was measured by flow cytometry. Using this assay and influenza virus as a control virus with a well-characterized receptor, a systematic search of cell surface molecules that might be implicated in HRSV binding was carried out. Treatment of cells with different enzymes or with other reagents suggested that heparin-like glycosaminoglycans (GAGs) were involved in attachment of HRSV, but not influenza virus, to host cells. This was further confirmed by a lack of binding of HRSV to CHO-K1 mutant cell lines deficient in glycosylation or GAGs biosynthesis and by an inhibition of binding after preincubation of virus with heparin and other GAGs. The degree of sulfation, more than the polysaccharide backbone of GAGs, seems to be critical for virus binding.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11038384     DOI: 10.1099/0022-1317-81-11-2715

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  43 in total

1.  Neutralization of human respiratory syncytial virus infectivity by antibodies and low-molecular-weight compounds targeted against the fusion glycoprotein.

Authors:  Margarita Magro; David Andreu; Paulino Gómez-Puertas; José A Melero; Concepción Palomo
Journal:  J Virol       Date:  2010-06-09       Impact factor: 5.103

2.  Cleavage at the furin consensus sequence RAR/KR(109) and presence of the intervening peptide of the respiratory syncytial virus fusion protein are dispensable for virus replication in cell culture.

Authors:  Gert Zimmer; Karl-Klaus Conzelmann; Georg Herrler
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

3.  Recombinant Sendai viruses expressing fusion proteins with two furin cleavage sites mimic the syncytial and receptor-independent infection properties of respiratory syncytial virus.

Authors:  Joanna Rawling; Olga Cano; Dominique Garcin; Daniel Kolakofsky; José A Melero
Journal:  J Virol       Date:  2011-01-12       Impact factor: 5.103

4.  Filoviruses utilize glycosaminoglycans for their attachment to target cells.

Authors:  Beatriz Salvador; Nicole R Sexton; Ricardo Carrion; Jerritt Nunneley; Jean L Patterson; Imke Steffen; Kai Lu; Marcus O Muench; David Lembo; Graham Simmons
Journal:  J Virol       Date:  2013-01-09       Impact factor: 5.103

5.  CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells.

Authors:  Tatiana Chirkova; Songbai Lin; Antonius G P Oomens; Kelsey A Gaston; Seyhan Boyoglu-Barnum; Jia Meng; Christopher C Stobart; Calvin U Cotton; Tina V Hartert; Martin L Moore; Assem G Ziady; Larry J Anderson
Journal:  J Gen Virol       Date:  2015-06-25       Impact factor: 3.891

6.  Hyperencapsulated mucoid pneumococcal isolates from patients with cystic fibrosis have increased biofilm density and persistence in vivo.

Authors:  Evida A Dennis; Mamie T Coats; Sarah Griffin; Bing Pang; David E Briles; Marilyn J Crain; W Edward Swords
Journal:  Pathog Dis       Date:  2018-10-01       Impact factor: 3.166

7.  Heparan sulfate proteoglycans mediate attachment and entry of human T-cell leukemia virus type 1 virions into CD4+ T cells.

Authors:  Kathryn S Jones; Cari Petrow-Sadowski; Daniel C Bertolette; Ying Huang; Francis W Ruscetti
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

8.  Effect of sialidase fusion protein (DAS 181) on human metapneumovirus infection of Hep-2 cells.

Authors:  Sutthiwan Thammawat; Tania A Sadlon; Penelope Adamson; David L Gordon
Journal:  Antivir Chem Chemother       Date:  2016-09-20

Review 9.  Structural, antigenic and immunogenic features of respiratory syncytial virus glycoproteins relevant for vaccine development.

Authors:  José A Melero; Vicente Mas; Jason S McLellan
Journal:  Vaccine       Date:  2016-09-28       Impact factor: 3.641

10.  RhoA-derived peptide dimers share mechanistic properties with other polyanionic inhibitors of respiratory syncytial virus (RSV), including disruption of viral attachment and dependence on RSV G.

Authors:  Philip J Budge; Yeqiang Li; Judy A Beeler; Barney S Graham
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.